Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Rigorous test-negative design study with large real-world population (73,160 cases) over 15 years demonstrating vaccine effectiveness against the target pathogen with precise confidence intervals; not practice-changing because vaccination policy was already implemented.
This is a comprehensive narrative review synthesizing molecular, cellular, and evolutionary evidence on PRRSV pathogenesis and vaccinology to frame a mechanistic understanding and strategic approach to intervention, without reporting original empirical data or clinical trials.
This is a narrative review synthesizing structure-guided protein engineering strategies and preclinical immunogenicity data, raising mechanistic questions about pre-F stabilization rather than reporting a definitive clinical or confirmatory experimental result.